Ricardo Benevides Freitas's questions to Sanofi SA (SNY) leadership • Q4 2024
Question
Ricardo Benevides Freitas from Santander inquired about the potential impact of proposed U.S. tariffs on APIs and pharmaceuticals on Sanofi's top line and operating income, and possible mitigation strategies.
Answer
CFO François-Xavier Roger stated it is difficult to comment on a hypothetical situation but noted that Sanofi has a significant industrial base in the U.S., with about 25% of what it markets worldwide being produced there.